2. QUALITATIVE AND QUANTITATIVE COMPOSITION
PRADAXA NZ DS v04 1 NEW ZEALAND DATASHEET . 1. PRODUCT NAME PRADAXA 75 mg hard capsules . PRADAXA 110 mg hard capsules . …
Download 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Name of the medicine - Baxter Healthcare
www.baxterhealthcare.com.auCERNEVIT Product Information . Name of the medicine. CERNEVIT. CERNEVIT is a multivitamin preparation, lyophilised, sterile powder, for reconstitution in5 mL
ESPEN Guidelines on Parenteral Nutrition: Adult …
espen.info1. Preliminary remarks The present guidelines address the indications for parenteral nutrition (PN) in renal patients with malnutrition in a similar way
Guidelines, Nutrition, Adults, Learn, Parenteral, Espen guidelines on parenteral nutrition, Espen
STANDARDS FOR INTENSIVE CARE UNITS - …
www.md.ucl.ac.be3 Categories of Organ System Monitoring and Support Department of Health, March 1996. 1. Advanced Respiratory Support · Mechanical ventilatory support excluding mask continuous positive
Standards, Unit, Care, Continuous, Intensive, Standards for intensive care units
Argatroban for anticoagulation in continuous renal ...
www.nimbot.comIn-in continuous renal replacement therapy:
Replacement, Therapy, Learn, Continuous, Continuous renal replacement therapy, Anticoagulation, Argatroban for anticoagulation in continuous renal, Argatroban
CRRT with Prismaflex LEADS TO More Flexibility, …
www.teknomedtr.comFor many years, Gambro has focused its efforts on development of continuous renal replacement therapies and other extra-corporeal blood purification therapies.
Replacement, Learn, Continuous, Continuous renal replacement
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu3 Table 1: Dose recommendations and duration of therapy for primary prevention of venous thromboembolism in orthopaedic surgery Treatment initiation
Product, Summary, Therapy, Characteristics, Summary of product characteristics
2000 - Jordan University of Science and Technology
www.just.edu.jo2000 Dialysis of Drugs Curtis A. Johnson, PharmD Member, Board of Directors Nephrology Pharmacy Associates Ann Arbor, Michigan …
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzDosage and Administration Dosage Adults and geriatric patients Hormone replacement therapy (HRT) involving either oestrogen-only or oestrogen-
Sheet, Data, Replacement, Therapy, Zealand, New zealand data sheet, Replacement therapy
Related search queries
Name of the medicine, ESPEN Guidelines on Parenteral Nutrition: Adult, Renal, STANDARDS FOR INTENSIVE CARE UNITS, Continuous, Argatroban for anticoagulation in continuous renal, Continuous renal replacement therapy, Continuous renal replacement, SUMMARY OF PRODUCT CHARACTERISTICS, Therapy, Dialysis, NEW ZEALAND DATA SHEET, Replacement therapy